12:00 AM
 | 
Feb 27, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Autologous umbilical cord blood: Phase I started

Cord Blood Registry began an open-label, U.S. Phase I trial to evaluate a single dose of 6 million cells/kg intravenous autologous umbilical cord...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >